HK:2696 Stock Latest News
Company AnnouncementsHenlius Seeks Higher Annual Cap on Fosun HANLIKANG Collaboration5d ago2696
Company AnnouncementsHenlius Biotech Reshapes Board Leadership With New Chairman and Director Changes1M ago2696
Company AnnouncementsShanghai Henlius Biotech Clarifies Board and Committee Structure1M ago2696
Company AnnouncementsHenlius Strikes Global T Cell Engager Deal with Amberstone1M ago2696- Company AnnouncementsHenlius Wins China NDA Acceptance for Denosumab Biosimilar HLX141M ago2696
Company AnnouncementsShanghai Henlius Added to Hong Kong Stock Connect Eligible Securities List1M ago2696Company AnnouncementsHenlius Delivers Strong Interim Growth and Expands EU Cancer Drug Footprint2M ago2696
Company AnnouncementsShanghai Henlius Biotech Added to Hang Seng Composite Index, Boosting Market Profile2M ago2696
Company AnnouncementsHenlius Strikes Global Biosimilar Alliance with Sandoz2M ago2696
Company AnnouncementsShanghai Henlius Biotech Sets August Board Meeting to Approve Interim Results3M ago2696- Company AnnouncementsHenlius Wins NMPA Nod to Start New HLX43 Combination Trials in China3M ago2696
Company AnnouncementsHenlius Starts First-in-Human Trial of Novel Trispecific Prostate Cancer Antibody3M ago2696
Company AnnouncementsShanghai Henlius Biotech Grants New Share Options and RSUs to Strengthen Incentives3M ago2696Company AnnouncementsHenlius Doses First Patient in Global Trial of Nivolumab Biosimilar HLX183M ago2696
Company AnnouncementsHenlius Wins NMPA Nod for HLX37 and HLX43 Combination Trial in Advanced Solid Tumours3M ago2696
- Company AnnouncementsHenlius Doses First Patient in Phase 1 Trial for Cetuximab Biosimilar HLX05-N3M ago2696
- Company AnnouncementsHenlius Starts First-in-Human Trial of Novel Dual-Target Cancer ADC HLX484M ago2696
- Company AnnouncementsHenlius Doses First U.S. Patient in Global Trial of Ipilimumab Biosimilar HLX134M ago2696
Company AnnouncementsHenlius wins EU nod for new lung cancer use of serplulimab4M ago2696
Company AnnouncementsHenlius Wins GMP Green Light for HANBEIYOU Production in Mainland China4M ago2696Company AnnouncementsHenlius Wins NMPA Nod for First-in-Class Trispecific Prostate Cancer Therapy Trial4M ago2696
